Page last updated: 2024-10-30

beta-lapachone and Adult Spinal Muscular Atrophy

beta-lapachone has been researched along with Adult Spinal Muscular Atrophy in 1 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Research Excerpts

ExcerptRelevanceReference
"Camptothecin treatment reduced the DNA relaxation activity of DNA topoisomerase I in human fibroblasts."1.35Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent. ( Funanage, VL; Gómez-Curet, I; Scavina, M; Wang, W; Wu, CY, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, CY1
Gómez-Curet, I1
Funanage, VL1
Scavina, M1
Wang, W1

Other Studies

1 other study available for beta-lapachone and Adult Spinal Muscular Atrophy

ArticleYear
Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent.
    BMC cell biology, 2009, May-16, Volume: 10

    Topics: Apoptosis; Camptothecin; Cells, Cultured; DNA Topoisomerases, Type I; Fibroblasts; Humans; Muscular

2009